Semliki Forest Virus-Based Expression of Recombinant GPCRs

被引:0
|
作者
Lundstrom, Kenneth [1 ]
机构
[1] PanTherapeutics, Lutry, Switzerland
关键词
PROTEIN-COUPLED RECEPTOR; HIGH-LEVEL EXPRESSION; SINDBIS VIRUS; CELL-LINES; PHARMACOLOGICAL CHARACTERIZATION; MAMMALIAN-CELLS; GENE-EXPRESSION; 5-HT3; RECEPTOR; IN-VITRO; VECTORS;
D O I
10.1016/bs.mie.2014.11.047
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Due to their importance as targets for drug development, rapid and consistent high-level production of G protein-coupled receptors (GPCRs) has become an essential part of drug discovery. Alphaviruses, particularly recombinant Semliki Forest virus (SFV) particles, have provided the means for expression of a number of GPCRs in a broad range of mammalian host cell lines for pharmacological characterization by determination of receptor binding activity and functional coupling to G proteins. The rapid high-titer virus particle production has made it possible to study a large number of GPCRs in parallel. Moreover, large-scale production in adherent and suspension cultures of mammalian cells has provided sufficient amounts of GPCRs for purification and subsequent structural studies. Furthermore, the high preference for neuronal delivery of SFV particles has allowed functional and localization studies of recombinant proteins in hippocampal slice cultures, in primary neurons, and in vivo.
引用
收藏
页码:331 / 350
页数:20
相关论文
共 50 条
  • [41] Semliki forest virus encephalitis
    Fazakerley, JK
    ADVANCES IN ANIMAL VIROLOGY, 2000, : 217 - 225
  • [42] Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7
    van de Wall, Stephanie
    Walczak, Mateusz
    van Rooij, Nienke
    Hoogeboom, Baukje-Nynke
    Meijerhof, Tjarko
    Nijman, Hans W.
    Daemen, Toos
    VACCINES, 2015, 3 (02): : 221 - 238
  • [43] Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles
    Brand, D
    Lemiale, F
    Turbica, I
    Buzelay, L
    Brunet, S
    Barin, F
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (15) : 1369 - 1377
  • [44] Clinical applications of recombinant virus-based cancer immunotherapy
    Adamina, M
    Daetwiler, S
    Rosenthal, R
    Zajac, P
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (09) : 1211 - 1224
  • [45] Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures
    Ehrengruber, MU
    Lundstrom, K
    Schweitzer, C
    Heuss, C
    Schlesinger, S
    Gähwiler, BH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) : 7041 - 7046
  • [46] A NEW GENERATION OF ANIMAL-CELL EXPRESSION VECTORS BASED ON THE SEMLIKI FOREST VIRUS REPLICON
    LILJESTROM, P
    GAROFF, H
    BIO-TECHNOLOGY, 1991, 9 (12): : 1356 - 1361
  • [47] INFECTION, INTERACTION AND EXPRESSION OF VIRULENCE BY DEFINED STRAINS OF SEMLIKI FOREST VIRUS
    BRADISH, CJ
    ALLNER, K
    MABER, HB
    JOURNAL OF GENERAL VIROLOGY, 1972, 16 (SEP): : 359 - +
  • [48] The Semliki Forest virus system: Receptor expression and scale-up
    Lundstrom, K
    Blasey, H
    Hovius, R
    Vogel, H
    Bernard, A
    GENETIC ENGINEER AND BIOTECHNOLOGIST, 1997, 17 (2-3): : 101 - 106
  • [49] Recombinant Semliki Forest virus: selective gene delivery into balloon-injured vessels
    Roks, AJM
    Henning, RH
    van Gilst, WH
    Wilschut, JC
    Tio, RA
    EUROPEAN HEART JOURNAL, 2001, 22 : 4 - 4
  • [50] Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice
    Berglund, P
    Fleeton, MN
    Smerdou, C
    Liljeström, P
    VACCINE, 1999, 17 (05) : 497 - 507